Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide

被引：0
|
作者：
Jennifer R Elliott
Susan Manzi
机构：
[1] Associate Professor of Medicine and Epidemiology and co-Director of the Lupus Center of Excellence,
[2] Research Fellow in Rheumatology,undefined
[3] at the University of Pittsburgh School of Medicine,undefined
来源：
Nature Clinical Practice Rheumatology | 2006年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：354 / 355
页数：1
相关论文
共 50 条
  • [1] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Elliott, Jennifer R.
    Manzi, Susan
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 354 - 355
  • [2] Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide
    Christian Burchardi
    Detlef Schlöndorff
    Nature Clinical Practice Nephrology, 2006, 2 : 314 - 315
  • [3] Induction therapy for active lupus nephritis:: mycophenolate mofetil versus cyclophosphamide -: Commentary
    Burchardi, Christian
    Schloendorff, Detlef
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (06): : 314 - 315
  • [4] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    Eid M. El-Shafey
    Said H. Abdou
    Mohamed M. Shareef
    Clinical and Experimental Nephrology, 2010, 14 : 214 - 221
  • [5] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey, Eid M.
    Abdou, Said H.
    Shareef, Mohamed M.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 214 - 221
  • [6] INDUCTION THERAPY FOR PEDIATRIC ONSET LUPUS NEPHRITIS : MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE
    Eveillard, Laurye-anne
    Chbihi, Marwa
    Riller, Quentin
    Rabant, Marion
    Dehoux, Laurene
    Charbit, Marina
    Biebuyck, Nathalie
    Avramescu, Marina
    Bader-Meunier, Brigitte
    Boyer, Olivia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3378 - 3378
  • [7] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [8] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    中华医学杂志（英文版）, 2014, (21) : 3718 - 3723
  • [9] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    CHINESE MEDICAL JOURNAL, 2014, 127 (21) : 3718 - 3723
  • [10] Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
    Li, Xiao
    Ren, Hong
    Zhang, Qianying
    Zhang, Wen
    Wu, Xiaojing
    Xu, Yaowen
    Shen, Pingyan
    Chen, Nan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1467 - 1472
12345